InSite Vision, Inc.
Investors
Webcast ImageWebcast
Q4 2009 InSite Vision Incorporated Earnings Conference Call (Replay)
03/09/10 at 4:30 p.m. ET
Profile

InSite Vision is committed to advancing new and superior ophthalmologic products for unmet eye care needs. The Company's lead product is AzaSite*, which targets infections of the eye. AzaSite contains the drug azithromycin, a broad-spectrum antibiotic formulated with DuraSite, InSite Vision's patented drug-delivery vehicle, which offers the benefit of a low-dosing regimen, attractive to both the eye-care pati... More >>

Stock Quote
INSV (Common Stock)
Symbol INSV (Common Stock)
ExchangeOTC BB (US Dollar)
Price$0.43
Change (%) Stock is Down 0.03 (6.52%)
Volume225,490
Data as of 03/10/10 3:57 p.m. ET
Minimum 20 minute delay
Refresh quote
Receive E-mail AlertsE-mail Alert Icon
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Recent News More >>
DateTitle 
03/09/10InSite Vision Reports Full Year and Fourth Quarter 2009 Financial ResultsPrinter Friendly Version
03/03/10InSite Vision to Report Fourth Quarter and Year-End 2009 Financial Results on March 9, 2010Printer Friendly Version
12/15/09InSite Vision to Advance New Ocular Anti-Inflammatory CandidatePrinter Friendly Version
12/10/09InSite Vision Announces Webcast for Upcoming Annual Meeting of StockholdersPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.